sanofi nasdaq - Search News

Order byBest matchMost fresh

News

Sanofi buys Vigil Neuroscience for $470m

Sanofi to buy Vigil Neuroscience in $470M deal (update)

Sanofi (NASDAQ:SNY) said Wednesday it agreed to acquire clinical-stage biotechnology company Vigil Neuroscience (NASDAQ:VIGL) for $470M in cash, potentially reaching $600M with milestone payments. Following a trading halt,

Continue reading

· 2d · on MSN

· 2d · on MSN

Sanofi Set to Acquire Vigil Neuroscience in $470 Million Deal

Vigil Neuroscience Enters into Definitive Merger Agreement to be Acquired by Sanofi

Press Release: Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer’s disease to the neurology pipeline

while putting sustainability and social responsibility at the center of our ambitions. Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY ...

10don MSN

Sanofi will invest at least $20B in the U.S., focus on R&D spends

Sanofi (NASDAQ:SNY) will invest at least $20B in the U.S. through 2030 focusing on research and manufacturing, the company ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results